News & Blog

Tag Archives: immunotherapy

Translating Brain Tumor Science Into Survival

A version of the following article appeared originally in a special insert/section of USA TODAY today on 3/18/2016 called “Brain Health,” produced by Mediaplanet USA, as part of its “Future of Personal Health” campaign. In early 2016, the American Cancer Society released its annual “Cancer Statistics” report. The ensuing headlines in numerous media outlets broadcast the […]

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]

The Neuro-Oncology Field Weighs-in: Predictions & Hopes for Brain Tumor Research Advances in 2016

In 2015 we saw a major swing toward positive momentum in the fight against brain tumors, and we’re carrying it into 2016. Last year we experienced the first new treatment for newly diagnosed glioblastoma patients approved to enter the market in nearly a decade, as well as the biggest single-year increase in funding for the […]

Share